Structural basis of NR2B-selective antagonist recognition by N-methyl-D-aspartate receptors.
D000409:Alanine / Q000378:metabolism; D000595:Amino Acid Sequence; D019943:Amino Acid Substitution; D000818:Animals; D003545:Cysteine / Q000378:metabolism; D018076:DNA, Complementary / Q000235:genetics / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D004594:Electrophysiology; D005260:Female; D018698:Glutamic Acid / Q000737:chemistry; D005998:Glycine / Q000737:chemistry; D006863:Hydrogen-Ion Concentration; D020128:Inhibitory Concentration 50; D051379:Mice; D008845:Microinjections; D008958:Models, Molecular; D008968:Molecular Conformation; D008969:Molecular Sequence Data; D009865:Oocytes / Q000378:metabolism; D018408:Patch-Clamp Techniques; D010880:Piperidines; D010957:Plasmids; D017433:Protein Structure, Secondary; D017434:Protein Structure, Tertiary; D051381:Rats; D016194:Receptors, N-Methyl-D-Aspartate / Q000037:antagonists & inhibitors* / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism; D011993:Recombinant Fusion Proteins / Q000378:metabolism; D012015:Reference Standards; D017386:Sequence Homology, Amino Acid; D013696:Temperature; D014982:Xenopus laevis; D015032:Zinc / Q000494:pharmacology
D018076:DNA, Complementary; D010880:Piperidines; D016194:Receptors, N-Methyl-D-Aspartate; D011993:Recombinant Fusion Proteins; D018698:Glutamic Acid; D015032:Zinc; D003545:Cysteine; D000409:Alanine; C010739:ifenprodil; D005998:Glycine